等待开盘 09-26 09:30:00 美东时间
+0.380
+0.45%
General Dynamics Information Technology (GDIT), a business unit of General Dynamics (NYSE: GD), announced Thursday that it was awarded an enterprise IT modernizatio
今天 02:00
General Dynamics Corp - Gdit to Cut Costs and Increase Efficiency for Stratcom
今天 00:30
STRATA Skin Sciences, Inc. ("STRATA" or the "Company") (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions,
09-22 20:22
来自美国能源巨头西方石油公司(Occidental Petroleum Corp.)碳清除业务部门的负责人表示,开发直接空气捕获项目的初创企业若要扩大这项技术的...
09-19 07:06
据路透社报道,一项新调查显示,超过一半的美国医疗保健工作者正积极寻求离开当前岗位。 此项由教育服务公司 Strategic Education 委托的哈里斯民意...
09-15 20:55
STRATA Skin Sciences, Inc. has entered into definitive agreements with institutional investors to sell 1,097,547 shares of common stock at $2.204 per share through a registered direct offering under Nasdaq rules. The offering is priced at-market and expected to close on September 4, 2025, subject to customary conditions. Gross proceeds to the Company are approximately $2.42 million, with net proceeds intended for working capital and general corpo...
09-03 12:00
Wall Street didn't take kindly to this morning's hotter-than-expected producer inflation report.
08-14 22:01
STRATA Skin Sciences is working with CMS to secure temporary codes to accelerate reimbursement for its XTRAC® excimer laser treatment, expanding its use for inflammatory and autoimmune skin conditions. Recent peer-reviewed studies confirm the efficacy of 308-nm excimer laser therapy combined with JAK inhibitors for vitiligo, achieving high repigmentation rates. The company also updated its litigation against LaserOptek America, adding LaserOptek ...
08-07 12:15
EXECUTING ON CORE GROWTH STRATEGY AND REAFFIRMING 2025 FINANCIAL GUIDANCE RANGES Reported second-quarter 2025 Net income attributable to limited partners of $333.8 million, generating record...
08-07 04:07
今日重点评级关注:花旗:维持Apellis Pharmaceuticals"买入"评级,目标价从46美元升至52美元;BTIG:维持Strategy"买入"评级,目标价从620美元升至700美元
08-04 09:30